Pigmented nodular melanoma: the predictive value of dermoscopic features using multivariate analysis. 2015

M A Pizzichetta, and H Kittler, and I Stanganelli, and R Bono, and S Cavicchini, and V De Giorgi, and G Ghigliotti, and P Quaglino, and P Rubegni, and G Argenziano, and R Talamini, and
Division of Medical Oncology - Preventive Oncology, Centro di Riferimento Oncologico, National Cancer Institute, Via Franco Gallini, 2, 33081, Aviano, Italy.

BACKGROUND Nodular melanoma (NM), representing 10-30% of all melanomas, plays a major role in global mortality related to melanoma. Nonetheless, the literature on dermoscopy of NM is scanty. OBJECTIVE To assess odds ratios (ORs) to quantify dermoscopic features of pigmented NM vs. pigmented superficial spreading melanoma (SSM), and pigmented nodular nonmelanocytic and benign melanocytic lesions. METHODS To assess the presence or absence of global patterns and dermoscopic criteria, digitized images of 457 pigmented skin lesions from patients with a histopathological diagnosis of NM (n = 75), SSM (n = 93), and nodular nonmelanocytic and benign melanocytic lesions (n = 289; namely, 39 basal cell carcinomas, 85 seborrhoeic keratoses, 81 blue naevi, and 84 compound/dermal naevi) were retrospectively collected and blindly evaluated by three observers. RESULTS Multivariate analysis showed that ulceration (OR 4.07), homogeneous disorganized pattern (OR 10.76), and homogeneous blue pigmented structureless areas (OR 2.37) were significantly independent prognostic factors for NM vs. SSM. Multivariate analysis of dermoscopic features of NM vs. nonmelanocytic and benign melanocytic lesions showed that the positive correlating features leading to a significantly increased risk of NM were asymmetric pigmentation (OR 6.70), blue-black pigmented areas (OR 7.15), homogeneous disorganized pattern (OR 9.62), a combination of polymorphous vessels and milky-red globules/areas (OR 23.65), and polymorphous vessels combined with homogeneous red areas (OR 33.88). CONCLUSIONS Dermoscopy may be helpful in improving the recognition of pigmented NM by revealing asymmetric pigmentation, blue-black pigmented areas, homogeneous disorganized pattern and abnormal vascular structures, including polymorphous vessels, milky-red globules/areas and homogeneous red areas.

UI MeSH Term Description Entries
D008297 Male Males
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009508 Nevus, Pigmented A nevus containing melanin. The term is usually restricted to nevocytic nevi (round or oval collections of melanin-containing nevus cells occurring at the dermoepidermal junction of the skin or in the dermis proper) or moles, but may be applied to other pigmented nevi. Nevus, Melanocytic,Nevi, Melanocytic,Nevi, Pigmented,Pigmented Moles,Melanocytic Nevi,Melanocytic Nevus,Pigmented Nevi,Pigmented Nevus
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D002280 Carcinoma, Basal Cell A malignant skin neoplasm that seldom metastasizes but has potentialities for local invasion and destruction. Clinically it is divided into types: nodular, cicatricial, morphaic, and erythematoid (pagetoid). They develop on hair-bearing skin, most commonly on sun-exposed areas. Approximately 85% are found on the head and neck area and the remaining 15% on the trunk and limbs. (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1471) Carcinoma, Basal Cell, Pigmented,Epithelioma, Basal Cell,Rodent Ulcer,Ulcer, Rodent,Basal Cell Carcinoma,Basal Cell Carcinomas,Basal Cell Epithelioma,Basal Cell Epitheliomas,Carcinomas, Basal Cell,Epitheliomas, Basal Cell,Rodent Ulcers,Ulcers, Rodent
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M A Pizzichetta, and H Kittler, and I Stanganelli, and R Bono, and S Cavicchini, and V De Giorgi, and G Ghigliotti, and P Quaglino, and P Rubegni, and G Argenziano, and R Talamini, and
March 2014, The Journal of dermatology,
M A Pizzichetta, and H Kittler, and I Stanganelli, and R Bono, and S Cavicchini, and V De Giorgi, and G Ghigliotti, and P Quaglino, and P Rubegni, and G Argenziano, and R Talamini, and
December 2011, The British journal of dermatology,
M A Pizzichetta, and H Kittler, and I Stanganelli, and R Bono, and S Cavicchini, and V De Giorgi, and G Ghigliotti, and P Quaglino, and P Rubegni, and G Argenziano, and R Talamini, and
December 2013, Annales de dermatologie et de venereologie,
M A Pizzichetta, and H Kittler, and I Stanganelli, and R Bono, and S Cavicchini, and V De Giorgi, and G Ghigliotti, and P Quaglino, and P Rubegni, and G Argenziano, and R Talamini, and
June 2013, JAMA dermatology,
M A Pizzichetta, and H Kittler, and I Stanganelli, and R Bono, and S Cavicchini, and V De Giorgi, and G Ghigliotti, and P Quaglino, and P Rubegni, and G Argenziano, and R Talamini, and
July 2010, Acta dermato-venereologica,
M A Pizzichetta, and H Kittler, and I Stanganelli, and R Bono, and S Cavicchini, and V De Giorgi, and G Ghigliotti, and P Quaglino, and P Rubegni, and G Argenziano, and R Talamini, and
May 2019, The Journal of dermatology,
M A Pizzichetta, and H Kittler, and I Stanganelli, and R Bono, and S Cavicchini, and V De Giorgi, and G Ghigliotti, and P Quaglino, and P Rubegni, and G Argenziano, and R Talamini, and
May 2019, International journal of dermatology,
M A Pizzichetta, and H Kittler, and I Stanganelli, and R Bono, and S Cavicchini, and V De Giorgi, and G Ghigliotti, and P Quaglino, and P Rubegni, and G Argenziano, and R Talamini, and
May 2015, Journal of the European Academy of Dermatology and Venereology : JEADV,
M A Pizzichetta, and H Kittler, and I Stanganelli, and R Bono, and S Cavicchini, and V De Giorgi, and G Ghigliotti, and P Quaglino, and P Rubegni, and G Argenziano, and R Talamini, and
January 2020, Dermatology practical & conceptual,
M A Pizzichetta, and H Kittler, and I Stanganelli, and R Bono, and S Cavicchini, and V De Giorgi, and G Ghigliotti, and P Quaglino, and P Rubegni, and G Argenziano, and R Talamini, and
January 2010, Dermatology research and practice,
Copied contents to your clipboard!